To Combine or Not to Combine Chemotherapy and Immunotherapy, Is That the Question in Endometrial Cancer?

Afleveringen

Living With Endometrial Cancer: Understanding Patient Perspectives to Improve Overall Care
15 feb 2024· Breaking the Silence: Navigating Advanced Endometrial Cancer
Join for a discussion on the impact of endometrial cancer (EC) on patients' quality of life (QoL).

Credit available for this activity expires: 2/15/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000137?ecd=bdc_podcast_libsyn_mscpedu
- Luisteren Nogmaals beluisteren Doorgaan Wordt afgespeeld...
- Later beluisteren Later beluisteren
More Than High and Low Risk: How We Have Learned That Endometrial Cancer Is Not a Single Malignancy
22 dec 2023· Breaking the Silence: Navigating Advanced Endometrial Cancer
The experts discuss subtypes and molecular classification of endometrial cancer (EC).

Credit available for this activity expires: 12/22/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999291?ecd=bdc_podcast_libsyn_mscpedu
- Luisteren Nogmaals beluisteren Doorgaan Wordt afgespeeld...
- Later beluisteren Later beluisteren
Zijn er afleveringen die ontbreken?

Klik hier om de feed te vernieuwen.
Beyond Primary Treatment: How Else Can We Benefit Our Patients Through a Holistic Approach to Care?
20 dec 2023· Breaking the Silence: Navigating Advanced Endometrial Cancer
The experts discuss how to support patients during treatment for endometrial cancer (EC).

Credit available for this activity expires: 12/20/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999343?ecd=bdc_podcast_libsyn_mscpedu
- Luisteren Nogmaals beluisteren Doorgaan Wordt afgespeeld...
- Later beluisteren Later beluisteren
The Hottest Topic in Endometrial Cancer: Where Is the Therapeutic Landscape Moving to and What Are the Data to Support This?
20 dec 2023· Breaking the Silence: Navigating Advanced Endometrial Cancer
The experts discuss recent clinical trial data in endometrial cancer (EC).

Credit available for this activity expires: 12/20/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999338?ecd=bdc_podcast_libsyn_mscpedu
- Luisteren Nogmaals beluisteren Doorgaan Wordt afgespeeld...
- Later beluisteren Later beluisteren
To Combine or Not to Combine Chemotherapy and Immunotherapy, Is That the Question in Endometrial Cancer?
19 dec 2023· Breaking the Silence: Navigating Advanced Endometrial Cancer
Join the experts for a discussion chemotherapy and immunotherapy in treating metastatic endometrial cancer (EC).

Credit available for this activity expires: 12/19/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999289?ecd=bdc_podcast_libsyn_mscpedu
- Luisteren Nogmaals beluisteren Doorgaan Wordt afgespeeld...
- Later beluisteren Later beluisteren
The Story So Far: The Long and Short of Clinical Development in Endometrial Cancer
11 dec 2023· Breaking the Silence: Navigating Advanced Endometrial Cancer
Dr Banerjee presents the history of the last 10 years in endometrial cancer (EC).

Credit available for this activity expires: 12/8/2024
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999026?ecd=bdc_podcast_libsyn_mscpedu
- Luisteren Nogmaals beluisteren Doorgaan Wordt afgespeeld...
- Later beluisteren Later beluisteren

Afleveringen

Living With Endometrial Cancer: Understanding Patient Perspectives to Improve Overall Care

More Than High and Low Risk: How We Have Learned That Endometrial Cancer Is Not a Single Malignancy

Beyond Primary Treatment: How Else Can We Benefit Our Patients Through a Holistic Approach to Care?

The Hottest Topic in Endometrial Cancer: Where Is the Therapeutic Landscape Moving to and What Are the Data to Support This?

The Story So Far: The Long and Short of Clinical Development in Endometrial Cancer